Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × olaparib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Ovarian Neoplasms 31 Prostatic Neoplasms 18 Fallopian Tube Neoplasms 16 Triple Negative Breast Neoplasms 15 Neoplasm Metastasis 11 Neoplasms 9 Pancreatic Neoplasms 8 Endometrial Neoplasms 8 Small Cell Lung Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 5 Sarcoma 5 Glioma 5 Lung Neoplasms 4 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Metastatic Castration-resistant Prostate Cancer 3 Lymphoma, Non-Hodgkin 3 Cholangiocarcinoma 3 Carcinoma, Ovarian Epithelial 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Pathologic Complete Response 2 Osteosarcoma 2

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡